U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403565) titled 'To Evaluate the Efficacy and Safety of the Insulin Patch Pump System in Patients With Diabetes.' on Dec. 15, 2025.
Brief Summary: Patients will be enrolled and randomly assigned to either the test group or the control group for short-time intensive insulin therapy in inpatient setting. The test group will receive treatment with the Insulin Patch Pump System, while the control group will be treated with the Medtronic MMT-1805 insulin pump (MiniMed 700). The treatment period will last 7 days, during which blood glucose monitoring will be conducted in both groups.
Study Start Date: June 14, 2025
Study Type: INTERVENTIONAL
Condition:...